Table 3.
QTLs surpassing the significance threshold (P < 5 × 10-7) for evidence of an association with tolerance.
| BTA1 | QTL start (bp) | QTL end (bp) | P-value most significant SNP | SNP position 2 | SNP ID | Annotation | Genes in QTL 3 | N° ofsignificant SNPs in QTL |
|---|---|---|---|---|---|---|---|---|
| 16 | 21307714 | 22307714 | 1,58E-07 | 21807714 | SPATA17, RRP15, TGFB2, U6 | 1 | ||
| 9 | 100997090 | 101997090 | 1,60E-07 | 101497090 | rs436366135 | Intron | TBXT,U6, SFT2D1, MPC1, RPS6KA2, RNASET2, CEP43, CCR6, GPR31, U4, TTLL2, UNC93A, ENSBTAG0000051317, ENSBTAG00000050267, ENSBTAG00000054087, ENSBTAG00000053924 | 1 |
| 4 | 66265303 | 67309158 | 2,55E-07 | 66765303 | rs382143408 | Intron | PLEKHA8, SCRN1, FKBP14, WIPF3, PRR15, CHN2, CPVL, TRIL, CREB5, ENSBTAG00000054573 | 8 |
| 26 | 20050339 | 21059555 | 2,92E-07 | 20559555 | rs381461650 | Intergenic | CNNM1, GOT1, U6, NKX2-3, SLC25A28, ENTPD7, COX15, CUTC, ABCC2, DNMBP, CPN1, ERLIN1, CHUK, ENSBTAG00000052639, ENSBTAG00000050951, ENSBTAG00000045082, ENSBTAG00000044887, ENSBTAG00000033021, ENSBTAG00000023939 | 2 |
| 16 | 71510469 | 72510469 | 3,61E-07 | 72010469 | rs210839825 | Intron | DTL, INTS7, LPGAT1, NEK2, SLC30A1, RD3, TRAF5, RCOR3, KCNH1, ENSBTAG00000048992, ENSBTAG00000048697, ENSBTAG00000050969, ENSBTAG00000053608 | 1 |
| 26 | 33908564 | 34908564 | 3,69E-07 | 34408564 | rs210720477 | Intergenic | HABP2, NRAP, CASP7, PLEKHS1, NHLRC2, DCLRE1A, ADRB1, CCDC186, TDRD1, VWA2, AFAP1L2, bta-mir2285dg, ABLIM1, ENSBTAG00000051735, ENSBTAG00000053724 | 1 |
| 25 | 11894597 | 12930197 | 3,81E-07 | 12394597 | rs109954622 | Intergenic | ERCC4 | 12 |
| 25 | 8908535 | 9991143 | 3,93E-07 | 9408535 | rs380720091 | Intron | U6, ATF7IP6, EMP2, TEKT5, NUBP1, TVP23A, CIITA, DEXI, CLEC16A, SOCS1, RMI2, TNP2, PRM1, PRM2, PRM3, ENSBTAG00000052111 | 13 |
| 4 | 80073101 | 81073101 | 4,02E-07 | 80573101 | rs379792050 | Intron | SUGCT, MPLKIP, CDK13, ENSBTAG00000049322 | 1 |
1QTL location, 2SNP location in the genome, 3Candidate genes located within the identified QTL.